Understanding antidepressant clinical trial results: Dextromethorphan-bupropion (Auvelity™)

This article was first published on September 5, 2022. It was last edited or updated on September 11, 2022. In August 2022, the United States Food and Drug Administration (FDA) approved the combination of dextromethorphan and bupropion (brand name Auvelity™) for the treatment of major depressive disorder (MDD). Note that the FDA indication is NOT…